1. |
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment. Stroke, 1993, 24(1): 35-41.
|
2. |
Eckerle B, Massaro A. Lumpers or splitters: evaluation and management of embolic stroke of undetermined source. Neurology, 2016, 87(10): 972-973.
|
3. |
Hart RG, Catanese L, Perera KS, et al. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke, 2017, 48(4): 867-872.
|
4. |
Paciaroni M, Kamel H. Do the results of RE-SPECT ESUS call for a revision of the embolic stroke of undetermined source definition?. Stroke, 2019, 50(4): 1032-1033.
|
5. |
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014, 45(7): 2160-2236.
|
6. |
Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol, 2014, 13(4): 429-438.
|
7. |
Kamel H, Merkler AE, Iadecola C, et al. Tailoring the approach to embolic stroke of undetermined source: a review. JAMA Neurol, 2019, 76(7): 855-861.
|
8. |
Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med, 2018, 378(23): 2191-2201.
|
9. |
Diener HC, Sacco RL, Easton JD, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med, 2019, 380(20): 1906-1917.
|
10. |
Geisler T, Poli S, Meisner C, et al. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design. Int J Stroke, 2017, 12(9): 985-990.
|
11. |
Geisler T, Mengel A, Ziemann U, et al. Management of embolic stroke of undetermined source (ESUS). Drugs, 2018, 78(8): 823-831.
|
12. |
Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial. Eur Stroke J, 2016, 1(3): 146-154.
|
13. |
Kasner SE, Swaminathan B, Lavados P, et al. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol, 2018, 17(12): 1053-1060.
|
14. |
Diener HC, Bernstein R, Hart R, et al. Secondary stroke prevention in cryptogenic stroke and embolic stroke of undetermined source (ESUS). Curr Neurol Neurosci Rep, 2017, 17(9): 64.
|
15. |
Amarenco P, Albers GW, Denison H, et al. Ticagrelor versus aspirin in acute embolic stroke of undetermined source. Stroke, 2017, 48(9): 2480-2487.
|
16. |
Bembenek JP, Karlinski MA, Kurkowska-Jastrzebska I, et al. Embolic strokes of undetermined source in a cohort of Polish stroke patients. Neurol Sci, 2018, 39(6): 1041-1047.
|
17. |
Cantú-Brito C, Sampaio Silva G, Ameriso SF. Embolic stroke of undetermined source in Latin America: a review. Neurologist, 2017, 22(5): 171-181.
|
18. |
Dennis M. Embolic stroke of undetermined source: a therapeutic target?. Lancet Neurol, 2014, 13(4): 344-346.
|
19. |
Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med, 2014, 370(26): 2467-2477.
|
20. |
Katsanos AH, Bhole R, Frogoudaki A, et al. The value of transesophageal echocardiography for embolic strokes of undetermined source. Neurology, 2016, 87(10): 988-995.
|
21. |
Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation, 2002, 105(22): 2625-2631.
|
22. |
Amarenco P, Davis S, Jones EF, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke, 2014, 45(5): 1248-1257.
|
23. |
Nouh A, Hussain M, Mehta T, et al. Embolic strokes of unknown source and cryptogenic stroke: implications in clinical practice. Front Neurol, 2016, 7: 37.
|
24. |
Umemura T, Nishizawa S, Nakano Y, et al. Importance of finding embolic sources for patients with embolic stroke of undetermined source. J Stroke Cerebrovasc Dis, 2019, 28(7): 1810-1815.
|
25. |
Tirschwell DL, Taylor BL. Is embolic stroke of undetermined source shrinking?. Stroke, 2019, 50(9): 2290-2291.
|